Related Experiment Video
Updated: May 13, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Painless myocardial ischemia is associated with mortality in patients with chronic kidney disease
James B Wetmore1, Mike Broce, Amer Malas
1Division of Nephrology and Hypertension, University of Kansas Medical Center, Kansas City, Kans 66160, USA. jwetmore @ kumc.edu
Insights
Painless myocardial ischemia (PMI) is common in chronic kidney disease (CKD) patients and linked to lower kidney function. This condition significantly increases mortality risk in CKD individuals.
Area of Science:
- Cardiology
- Nephrology
- Clinical Outcomes Research
Background:
- Painless myocardial ischemia (PMI) is linked to adverse outcomes in the general population.
- Chronic kidney disease (CKD) is associated with increased cardiovascular risk and mortality.
- The relationship between PMI, kidney function, and survival in CKD patients remains unclear.
Purpose of the Study:
- To investigate the prevalence of PMI in patients with varying levels of kidney function.
- To determine the association between PMI, CKD, and long-term mortality.
- To explore if PMI contributes to the high cardiovascular mortality observed in CKD.
Main Methods:
- A cohort of 356 patients undergoing percutaneous coronary intervention were evaluated.
- Painless myocardial ischemia (PMI) was defined as the absence of chest pain during balloon angioplasty.
- Cox proportional hazards models were used to assess 10-year all-cause mortality risk.
Main Results:
- PMI prevalence increased with declining estimated glomerular filtration rate (eGFR), from 20.6% (eGFR ≥ 90) to 50.0% (eGFR < 30).
- Individuals with both CKD and PMI exhibited the highest 10-year mortality risk (HR 2.08).
- CKD alone was associated with increased mortality (HR 1.64) compared to those without CKD or PMI.
Conclusions:
- Painless myocardial ischemia is highly prevalent in the CKD population and inversely correlates with eGFR.
- PMI significantly elevates mortality risk in CKD patients, potentially explaining some of the excess cardiovascular mortality.
- These findings highlight the importance of identifying PMI in CKD patients for risk stratification and management.
Background:
Painless myocardial ischemia (PMI) is associated with poor outcomes in the general population. We hypothesized that the presence of PMI is inversely related to the level of kidney function and is associated with impaired survival in chronic kidney disease (CKD).
Methods:
A total of 356 patients who underwent percutaneous coronary intervention were assessed for PMI, which was defined as the absence of chest pain in response to balloon dilation of the affected vessel. Cox proportional hazards analysis was used to calculate 10-year all-cause mortality.
Results:
There was an increase in PMI occurrence by strata of estimated glomerular filtration rate (eGFR), whereby PMI was present in only 20.6% of individuals with eGFR ≥ 90 ml/min/1.73 m(2), but was found in 50.0% of individuals with eGFR <30 ml/min/1.73 m(2) (p = 0.004 for trend). Classification of individuals as having either CKD or PMI showed significant differences in adjusted mortality between groups (p < 0.001 for trend), with individuals having both CKD and PMI demonstrating the highest 10-year mortality. Compared to individuals with neither CKD nor PMI, individuals with CKD and no PMI had a hazard ratio (HR) for mortality of 1.64 (95% CI: 1.03-2.63, p = 0.038), while individuals with both PMI and CKD had an HR of 2.08 (1.30-3.33, p = 0.002).
Conclusion:
PMI is common in the CKD population, is inversely related to the level of eGFR, and confers a substantially increased risk in CKD. These findings may partially explain the high mortality traditionally attributed to cardiovascular disease in CKD patients.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury I: Introduction
